Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

China SXT Pharmaceuticals (SXTC) Invested Capital: 2017-2025

Historic Invested Capital for China SXT Pharmaceuticals (SXTC) over the last 9 years, with Mar 2025 value amounting to $15.5 million.

  • China SXT Pharmaceuticals' Invested Capital rose 34.03% to $20.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.3 million, marking a year-over-year increase of 34.03%. This contributed to the annual value of $15.5 million for FY2025, which is 10.60% up from last year.
  • As of FY2025, China SXT Pharmaceuticals' Invested Capital stood at $15.5 million, which was up 10.60% from $14.0 million recorded in FY2024.
  • Over the past 5 years, China SXT Pharmaceuticals' Invested Capital peaked at $28.1 million during FY2021, and registered a low of $14.0 million during FY2024.
  • Over the past 3 years, China SXT Pharmaceuticals' median Invested Capital value was $14.8 million (recorded in 2023), while the average stood at $14.8 million.
  • As far as peak fluctuations go, China SXT Pharmaceuticals' Invested Capital skyrocketed by 197.84% in 2021, and later slumped by 37.58% in 2022.
  • Yearly analysis of 5 years shows China SXT Pharmaceuticals' Invested Capital stood at $28.1 million in 2021, then crashed by 37.58% to $17.5 million in 2022, then fell by 15.74% to $14.8 million in 2023, then declined by 4.99% to $14.0 million in 2024, then grew by 10.60% to $15.5 million in 2025.